Published in J Clin Microbiol on September 26, 2012
Genome fingerprinting by simple sequence repeat (SSR)-anchored polymerase chain reaction amplification. Genomics (1994) 6.40
Morphologic criteria for the preliminary identification of Fusarium, Paecilomyces, and Acremonium species by histopathology. Am J Clin Pathol (1998) 2.30
Acremonium species: new emerging fungal opportunists--in vitro antifungal susceptibilities and review. Clin Infect Dis (1997) 1.79
Acremonium phylogenetic overview and revision of Gliomastix, Sarocladium, and Trichothecium. Stud Mycol (2011) 1.47
Spectrum of clinically relevant Acremonium species in the United States. J Clin Microbiol (2010) 1.35
Acremonium species: a review of the etiological agents of emerging hyalohyphomycosis. Mycopathologia (2010) 1.22
Entomopathogenic fungus as a biological control for an important vector of livestock disease: the Culicoides biting midge. PLoS One (2011) 1.04
Mitochondrial gene sequences alone or combined with ITS region sequences provide firm molecular criteria for the classification of Lecanicillium species. Mycol Res (2008) 1.00
Aspergillus alabamensis, a new clinically relevant species in the section Terrei. Eukaryot Cell (2009) 1.00
Human exposure to airborne fungi from genera used as biocontrol agents in plant production. Ann Agric Environ Med (2007) 0.90
Mycoparasitism of Acremonium strictum BCP on Botrytis cinerea, the gray mold pathogen. J Microbiol Biotechnol (2008) 0.87
[Antifungal susceptibility of Acremonium species using E-test and Sensititre]. Rev Esp Quimioter (2004) 0.86
Global population structure of Aspergillus terreus inferred by ISSR typing reveals geographical subclustering. BMC Microbiol (2011) 0.82
Effect of mycoparasitic fungi on the development of Sphaerotheca fusca in melon leaves. Mycol Res (2003) 0.80
Laboratory and field evaluations of entomopathogenic Lecanicillium attenuatum CNU-23 for control of green peach aphid (Myzus persicae). J Microbiol Biotechnol (2008) 0.79
Treatment of invasive infections due to rare or emerging yeasts and moulds. Expert Opin Pharmacother (2006) 0.78
Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant (2009) 5.10
Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program. J Clin Microbiol (2004) 4.51
Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective Th1 responses to herpes simplex virus-2. J Exp Med (2003) 3.86
Necrotizing cutaneous mucormycosis after a tornado in Joplin, Missouri, in 2011. N Engl J Med (2012) 3.26
The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992-2000. Clin Infect Dis (2003) 3.04
Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance. J Infect Dis (2004) 2.98
Cryptococcal meningitis: improving access to essential antifungal medicines in resource-poor countries. Lancet Infect Dis (2013) 2.71
Transmission of Yersinia pestis from an infectious biofilm in the flea vector. J Infect Dis (2004) 2.52
Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants. Blood (2003) 2.40
Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole. Clin Infect Dis (2004) 2.31
Histopathologic diagnosis of fungal infections in the 21st century. Clin Microbiol Rev (2011) 2.27
Evaluation of a newly developed lateral flow immunoassay for the diagnosis of cryptococcosis. Clin Infect Dis (2011) 2.26
LaeA, a regulator of morphogenetic fungal virulence factors. Eukaryot Cell (2005) 2.21
Comparison of visual and spectrophotometric methods of broth microdilution MIC end point determination and evaluation of a sterol quantitation method for in vitro susceptibility testing of fluconazole and itraconazole against trailing and nontrailing Candida isolates. Antimicrob Agents Chemother (2002) 2.20
Molecular phylogenetic diversity, multilocus haplotype nomenclature, and in vitro antifungal resistance within the Fusarium solani species complex. J Clin Microbiol (2008) 2.16
Factors associated with mortality in transplant patients with invasive aspergillosis. Clin Infect Dis (2010) 2.15
Fungal infections associated with contaminated methylprednisolone injections. N Engl J Med (2012) 2.12
Azole resistance in Aspergillus fumigatus isolates from the ARTEMIS global surveillance study is primarily due to the TR/L98H mutation in the cyp51A gene. Antimicrob Agents Chemother (2011) 2.01
Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid. J Clin Microbiol (2004) 1.84
Utility of (1-3)-β-D-glucan testing for diagnostics and monitoring response to treatment during the multistate outbreak of fungal meningitis and other infections. Clin Infect Dis (2013) 1.82
FKS mutations and elevated echinocandin MIC values among Candida glabrata isolates from U.S. population-based surveillance. Antimicrob Agents Chemother (2010) 1.79
DNA and the classical way: identification of medically important molds in the 21st century. Med Mycol (2007) 1.69
Patterns of susceptibility of Aspergillus isolates recovered from patients enrolled in the Transplant-Associated Infection Surveillance Network. J Clin Microbiol (2009) 1.68
Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from 2008 to 2011. J Clin Microbiol (2012) 1.68
Molecular identification of Aspergillus species collected for the Transplant-Associated Infection Surveillance Network. J Clin Microbiol (2009) 1.67
Surveillance for bacterial diarrhea and antimicrobial resistance in rural western Kenya, 1997-2003. Clin Infect Dis (2006) 1.67
Epidemiologic and molecular characterization of an outbreak of Candida parapsilosis bloodstream infections in a community hospital. J Clin Microbiol (2004) 1.66
GliZ, a transcriptional regulator of gliotoxin biosynthesis, contributes to Aspergillus fumigatus virulence. Infect Immun (2006) 1.61
Population-based surveillance for cryptococcosis in an antiretroviral-naive South African province with a high HIV seroprevalence. AIDS (2006) 1.55
Internet-accessible DNA sequence database for identifying fusaria from human and animal infections. J Clin Microbiol (2010) 1.51
Multistate outbreak of listeriosis associated with cantaloupe. N Engl J Med (2013) 1.49
Prevalence of the use of central venous access devices within and outside of the intensive care unit: results of a survey among hospitals in the prevention epicenter program of the Centers for Disease Control and Prevention. Infect Control Hosp Epidemiol (2003) 1.47
Antifungal therapy and length of hospitalization in transplant patients with invasive aspergillosis. Med Mycol (2012) 1.44
Letter to the editor regarding "healthcare personnel attire in non-operating-room settings" by Bearman et al. Infect Control Hosp Epidemiol (2014) 1.40
Web-based training improves knowledge about central line bloodstream infections. Infect Control Hosp Epidemiol (2011) 1.39
Correlation of genotype and in vitro susceptibilities of Cryptococcus gattii strains from the Pacific Northwest of the United States. J Clin Microbiol (2009) 1.35
Next-generation sequencing of Coccidioides immitis isolated during cluster investigation. Emerg Infect Dis (2011) 1.35
Cryptococcus gattii infection: characteristics and epidemiology of cases identified in a South African province with high HIV seroprevalence, 2002-2004. Clin Infect Dis (2006) 1.33
Whole genome sequence analysis of Cryptococcus gattii from the Pacific Northwest reveals unexpected diversity. PLoS One (2011) 1.33
Detection of fungal DNA in human body fluids and tissues during a multistate outbreak of fungal meningitis and other infections. Eukaryot Cell (2013) 1.30
Enhanced surveillance of coccidioidomycosis, Arizona, USA, 2007-2008. Emerg Infect Dis (2010) 1.26
Preliminary laboratory report of fungal infections associated with contaminated methylprednisolone injections. J Clin Microbiol (2013) 1.25
Does cotrimoxazole prophylaxis for the prevention of HIV-associated opportunistic infections select for resistant pathogens in Kenyan adults? Am J Trop Med Hyg (2008) 1.23
Discovering potential pathogens among fungi identified as nonsporulating molds. J Clin Microbiol (2006) 1.22
Multiple origins of hybrid strains of Cryptococcus neoformans with serotype AD. Microbiology (2002) 1.22
Resolution of discrepant results for Candida species identification by using DNA probes. J Clin Microbiol (2004) 1.21
Cryptococcosis in a bottlenose dolphin (Tursiops truncatus) caused by Cryptococcus neoformans var. gattii. J Clin Microbiol (2002) 1.20
Coccidioidomycosis acquired in Washington State. Clin Infect Dis (2012) 1.19
Cryptococcal antigen screening and preemptive therapy in patients initiating antiretroviral therapy in resource-limited settings: a proposed algorithm for clinical implementation. J Int Assoc Physicians AIDS Care (Chic) (2012) 1.19
One fungus, one name: defining the genus Fusarium in a scientifically robust way that preserves longstanding use. Phytopathology (2013) 1.19
Preventing and treating biologic-associated opportunistic infections. Nat Rev Rheumatol (2009) 1.18
Utility of a Luminex-based assay for multiplexed, rapid species identification of Candida isolates from an ongoing candidemia surveillance. Can J Microbiol (2010) 1.17
Laboratory-confirmed cholera and rotavirus among patients with acute diarrhea in four hospitals in Haiti, 2012-2013. Am J Trop Med Hyg (2013) 1.17
Whole genome sequence typing to investigate the Apophysomyces outbreak following a tornado in Joplin, Missouri, 2011. PLoS One (2012) 1.16
Clinical findings for fungal infections caused by methylprednisolone injections. N Engl J Med (2013) 1.14
Differential role of MyD88 in macrophage-mediated responses to opportunistic fungal pathogens. Infect Immun (2003) 1.11
Cryptococcus gattii infections in multiple states outside the US Pacific Northwest. Emerg Infect Dis (2013) 1.09
Stability of allelic frequencies and distributions of Candida albicans microsatellite loci from U.S. population-based surveillance isolates. J Clin Microbiol (2003) 1.09
Indwelling urinary catheter management and catheter-associated urinary tract infection prevention practices in Nurses Improving Care for Healthsystem Elders hospitals. Am J Infect Control (2012) 1.08
Disseminated histoplasmosis in HIV-infected patients in South America: a neglected killer continues on its rampage. PLoS Negl Trop Dis (2013) 1.06
Phased implementation of screening for cryptococcal disease in South Africa. S Afr Med J (2012) 1.05
Central venous catheter infection associated with Pseudozyma aphidis in a child with short gut syndrome. J Med Microbiol (2008) 1.04
Aspergillus section Fumigati typing by PCR-restriction fragment polymorphism. J Clin Microbiol (2009) 1.03
Exserohilum infections associated with contaminated steroid injections: a clinicopathologic review of 40 cases. Am J Pathol (2013) 1.03
Development and validation of a microsphere-based Luminex assay for rapid identification of clinically relevant aspergilli. J Clin Microbiol (2009) 1.01
Nonsporulating clinical isolate identified as Petromyces alliaceus (anamorph Aspergillus alliaceus) by morphological and sequence-based methods. J Clin Microbiol (2007) 1.00
Methicillin-resistant Staphylococcus aureus ST9 in pigs in Thailand. PLoS One (2012) 0.99
Screening of a large global Aspergillus fumigatus species complex collection by using a species-specific microsphere-based Luminex assay. J Clin Microbiol (2009) 0.98
Development and evaluation of an enzyme-linked immunosorbent assay to detect Histoplasma capsulatum antigenuria in immunocompromised patients. Clin Vaccine Immunol (2009) 0.98
Laboratory-based Salmonella surveillance in Fiji, 2004-2005. Pac Health Dialog (2005) 0.98
Aspergillus terreus accessory conidia are unique in surface architecture, cell wall composition and germination kinetics. PLoS One (2009) 0.96
Cryptococcus gattii: where do we go from here? Med Mycol (2011) 0.96
Evaluation of a rapid lateral flow immunoassay for the detection of cryptococcal antigen for the early diagnosis of cryptococcosis in HIV patients in Colombia. Med Mycol (2013) 0.96
Evidence for a pseudo-outbreak of Candida guilliermondii fungemia in a university hospital in Brazil. J Clin Microbiol (2007) 0.95
Performance and utility of a rapid diagnostic test for cholera: notes from Haiti. Diagn Microbiol Infect Dis (2013) 0.94
Bacterial contamination of healthcare workers' uniforms: a randomized controlled trial of antimicrobial scrubs. J Hosp Med (2013) 0.94
Utility of CSP typing to sub-type clinical Aspergillus fumigatus isolates and proposal for a new CSP type nomenclature. J Microbiol Methods (2009) 0.94
Molecular analyses of Fusarium isolates recovered from a cluster of invasive mold infections in a Brazilian hospital. BMC Infect Dis (2013) 0.94
Preventing deaths from cryptococcal meningitis: from bench to bedside. Expert Rev Anti Infect Ther (2011) 0.93
Isolation of Aspergillus udagawae from a fatal case of feline orbital aspergillosis. Mycoses (2008) 0.93
High prevalence of cryptococcal infection among HIV-infected patients hospitalized with pneumonia in Thailand. Clin Infect Dis (2011) 0.93
A large outbreak of histoplasmosis among American travelers associated with a hotel in Acapulco, Mexico, spring 2001. Am J Trop Med Hyg (2003) 0.91
Determination of in vitro susceptibility of ocular Fusarium spp. isolates from keratitis cases and comparison of Clinical and Laboratory Standards Institute M38-A2 and E test methods. Diagn Microbiol Infect Dis (2008) 0.91
Mucormycosis outbreak associated with hospital linens. Pediatr Infect Dis J (2014) 0.89
Intradermal NKT cell activation during DNA priming in heterologous prime-boost vaccination enhances T cell responses and protection against Leishmania. Eur J Immunol (2008) 0.89